News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>CCBI Adds XPeng (XPEV.US) TP to US$25.6, Rating Outperform
Benefiting from improved operational efficiency, XPENG-W (09868.HK)(XPEV.US)'s 1Q25 gross profit margin improved to 15.6%, according to CCBI's research report.Management re...
Reset
Send
The window will close in 5 seconds
<Research>CCBI Adds XPeng (XPEV.US) TP to US$25.6, Rating Outperform
Close
Recommend
4
Positive
11
Negative
3
 
 

Benefiting from improved operational efficiency, XPENG-W (09868.HK)  -3.200 (-3.900%)    Short selling $690.76M; Ratio 29.473%   (XPEV.US)      's 1Q25 gross profit margin improved to 15.6%, according to CCBI's research report.

Management reiterated its guidance for positive net profit by 4Q25, supported mainly by the launch of three new models in the quarter, including the G7, a new P7 and a new hybrid SUV.

Related NewsCICC Lists HSTECH Constituent Adjustments/ Weighting Changes/ Passive Capital Change Forecasts (Table)
CCBI believed that the intensive rollout of new models and technologies boosted investor confidence, with the market generally expecting XPENG-W to become one of the leading autonomous driving pioneers among technology-oriented NEV startups.

Therefore, the broker kept rating at Outperform, and added its target price for XPENG-W's US stock from US$24.5 to US$25.6.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-23 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AASTOCKS Financial News
Website: www.aastocks.com

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.